Halifax Biomedical will Integrate IDC's X1590 into the First Standardized
Digital RSA Solution
CALGARY, Feb. 28 /PRNewswire-FirstCall/ - IDC (Imaging Dynamics Company Ltd.) (TSX: IDL), the global leader in digital radiography (DR) for image quality and value, today announced that Halifax Biomedical has selected IDC's X1590 as the DR component for an imaging product suite currently under development for conducting orthopaedic clinical trials for Roentgen Steriophotogrametric Analysis (RSA). Under a Canadian federal grant, Halifax Biomedical will interface its calibration technology with IDC's DR system and analytical software from Medis Specials of Holland to create the first standardized, fully digital RSA suite. The system will measure the stability of orthopaedic implants to a fraction of a millimeter and will be exhibited in the IDC booth #5430 at the American Academy of Orthopaedic Surgeons (AAOS) conference being held in San Francisco, March 5 - 7, 2008.
"We carefully evaluated every available digital radiography system and only IDC technology could meet our rigorous requirements," said Chad Munro, President of Halifax Biomedical. He added, "IDC's X-Series clearly contains the best technology for this type of precise, specialized application."
Halifax Biomedical delivers specialized contract research services and develops RSA-related imaging equipment for orthopaedic clinical trials. The product suite currently under development is designed to measure the stability of orthopaedic implants. Identifying the migration of implants into bone can be predictive of future failure of the implant due to aseptic loosening. RSA is also useful in assessing spinal fusion and fracture healing. Results from the first test of the product suite are expected to be available by the end of March, 2008. This test will be the backbone that allows expansion to a larger clinical network that will allow remote collaboration on standardized imaging systems.
"IDC continues to demonstrate its devotion to the orthopaedic healthcare market. This application illustrates that IDC DR technology meets the most stringent demands for image quality, accuracy and versatility," said Rick Sbordone, IDC Senior Vice President, N.A. Sales. "We are pleased to partner with Halifax Biomedical and break new ground in orthopaedic post-surgical follow-up care."
About Halifax Biomedical
Halifax Biomedical Inc. (HBI) is a contract research organization specializing in RSA research services and equipment including the RSA suite. HBI is based in Nova Scotia, Canada and is currently supporting eight clinical RSA trials in Halifax.
You may also visit the Halifax Biomedical web site: http://www.halifaxbiomedical.com
IDC (Imaging Dynamics Company) is a medical technology company and innovative force in the fast-growing field of digital radiography (DR) technology. IDC's X-Series of direct capture technology replaces conventional film-based X-rays and provides a cost-effective alternative to cassette based film or computed radiography (CR) systems.
Each IDC DR solution provides high resolution radiographic images in the digital format required for today's electronic medical record networks, all without the use of film, environmentally harmful chemicals, cassettes or expensive imaging plates. In addition to its number one ranking for three consecutive quarters for customer service by MD Buyline, IDC is the recipient of the 2007 Frost & Sullivan Technology Innovation Award and is among the 2007 Deloitte Technology Fast 500, which ranks the fastest growing technology, media, telecommunications and life sciences companies in North America.
IDC is based in Calgary, Alberta, Canada.
You may also visit the IDC Web site: http://www.imagingdynamics.com.
IDC will be exhibiting its products and technology at Booth #5430 at the AAOS 2008 in San Francisco from March 5 - 7.
Statements in this release which describe IDC's intentions, expectations or predictions, or which relate to matters that are not historical facts are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties which may cause the actual results, performances or achievements of IDC to be materially different from any future results, performances or achievements expressed in or implied by such forward-looking statements. IDC may update or revise any forward-looking statements, whether as a result of new information, future events or changing market and business conditions. Known and unknown risks and uncertainties include: IDC's ability to manufacture its products with a sufficient level of quality and in volumes which satisfy market demand; the ability of IDC to establish direct and indirect sales channels; the ability of IDC to establish industry partnerships; IDC's ability to attract and retain key personnel; the strength and breadth of IDC's patents; and other factors relating to general economic conditions, specific industry conditions and IDC's particular situation.
|SOURCE Imaging Dynamics Company Ltd.|
Copyright©2008 PR Newswire.
All rights reserved